Affiliation:
1. Cancer Institute, Xuzhou Medical University
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Reference41 articles.
1. 1) Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, Paz-Ares L. Lung cancer: current therapies and new targeted treatments. Lancet, 389, 299–311 (2017).
2. 2) Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin. Chest Med., 41, 1–24 (2020).
3. 3) Román M, Baraibar I, Lopez I, Nadal E, Rolfo C, Vicent S, Gil-Bazo I. KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Mol. Cancer, 17, 33 (2018).
4. 4) Parhizgar AR, Tahghighi A. Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iran. J. Med. Sci., 42, 115–128 (2017).
5. 5) Maguire A. Amodiaquine hydrochloride in the treatment of chronic discoid lupus erythematosus. Lancet, 279, 665–667 (1962).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献